Exciting News: Genotrial Joins Phase 2 of Enterprise Ireland’s New Frontiers Programme!

We’re delighted to share that Genotrial has been accepted into **Phase 2 of Enterprise Ireland’s New Frontiers Programme**! This is a big step for us as we work to transform clinical trials and make them better for everyone involved.

What Is the New Frontiers Programme?

The New Frontiers Programme is a prestigious initiative by Enterprise Ireland that helps promising startups grow and succeed. Being chosen for Phase 2 means we’ll receive:

• Funding to support our growth.
• Expert mentorship to guide us.
• Training to refine our business strategy.
• Networking opportunities with other startups and industry leaders.

This phase is all about helping us take Genotrial to the next level and prepare to bring our solution to the market.

Why This Matters

At Genotrial, our mission is to simplify clinical trials by improving patient recruitment and making the process more efficient. Many trials face delays because it’s hard to find the right patients. We’re creating tools to solve this problem, and this opportunity with New Frontiers will help us achieve our goals faster.

Thank You!

We’re so grateful to Enterprise Ireland for believing in our vision, and to everyone who has supported us so far. Your encouragement means the world to us!

What’s Next?

Over the next few months, we’ll focus on growing our team, improving our platform, and partnering with organizations that want to make clinical trials better.

Follow us on LinkedIn to stay updated on our journey!

Here’s to a brighter future for clinical trials—thank you for being part of it!